Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All...

Related Keywords

Australia ,Canada ,Switzerland ,United States ,China ,Belgium ,United Kingdom ,Melbourne ,Victoria ,Brussels ,Bruxelles Capitale ,Japan ,Australian ,Dedicaid Gmb ,Christian Behrenbruch ,Kyahn Williamson ,Telix Pharmaceuticals ,Drug Administration ,Australian Therapeutic Goods Administration ,European Union ,Prnewswire Telix Pharmaceuticals Limited ,Australian Securities Exchange ,Health Canada ,Telix Manufacturing Solutions ,Linkedin ,Pharmaceuticals Limited ,Grand Pharmaceutical Group Limited ,Brussels South ,Lightpoint Medical ,Managing Director ,Group Chief Executive Officer ,Marketing Authorisation Applications ,Limited Disclosure ,Telix Pharmaceuticals Limited ,